The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: A randomized controlled trial

Journal of Bone and Joint Surgery

Volumn 94, Issue 13, 2012, Pages 1160-1165

  Kim, Han Jo ^a   Fraser, M Robson ^a   Kahn, Barbara ^a   Lyman, Stephen ^a   Figgie, Mark P ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CLOPIDOGREL; FLOSEAL; HEMOGLOBIN; HEMOSTATIC AGENT; UNCLASSIFIED DRUG; WARFARIN;

ABSCESS; ANESTHESIA; ANTIBIOTIC THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CELLULITIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; KNEE; MAJOR CLINICAL STUDY; PARALYTIC ILEUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANGE OF MOTION; TOTAL KNEE REPLACEMENT; VISUAL ANALOG SCALE;

EID: 84863597118     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.00531     Document Type: Article

References (8)

1. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion. 1993 Jul;33(7):544-51. (Pubitemid 23210789)
2. Raut VV, Stone MH, Wroblewski BM. Reduction of postoperative blood loss after press-fit condylar knee arthroplasty with use of a femoral intramedullary plug. J Bone Joint Surg Am. 1993 Sep;75(9):1356-7. (Pubitemid 23331232)
3. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001 Oct;83-A(10):1503-5. (Pubitemid 32953347)
4. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am. 1999 Nov;81(11):1580-8.
5. Oz MC, Cosgrove DM 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, Topic N. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000 May;69(5):1376-82. (Pubitemid 30434861)
6. Renkens KL Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, Lawson KJ, Lentz R, Shuey H Jr, Conaway GL, Andersson GB, An HS, Hickey M, Rondinone JF, Shargill NS. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976). 2001 Aug 1;26(15):1645-50.
7. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 Feb;97(2):194-203. (Pubitemid 19061421)
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996 Jun 27;334(26):1685-90. (Pubitemid 26193619)